Teva Pharmaceutical Industries
Frank J. Mazzola, CMI, has extensive experience in taxation and auditing, currently serving as the Head of Indirect Tax - Americas at Teva Pharmaceuticals since July 2017. Previously, Frank held positions at Bristol-Myers Squibb from July 2012 to July 2017, including Associate Director of Taxation and Manager of Sales & Use Tax Audits and Compliance. Earlier roles included a Revenue Auditor at the Washington State Department of Revenue (June 1999 - July 2012) and an Accounting Specialist at The Prudential Insurance Company of America (January 1998 - July 1999). Frank began an auditing career at the New York State Insurance Fund from September 1994 to January 1998. Academic qualifications include a Master of Accountancy in Taxation from Rutgers Business School and a Graduate Certificate in State and Local Taxation from the University of Wisconsin-Milwaukee, along with a Bachelor's degree in Accounting and two associate degrees from the City University of New York, CSI.
This person is not in any teams
This person is not in any offices
Teva Pharmaceutical Industries
77 followers
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company headquartered in Petah Tikva, Israel. Teva Pharmaceuticals has been developing and producing medicines to help improve people’s lives for more than a century. They are committed to being a global leader in generic and specialty medicines with a portfolio of 3,500 products in nearly every therapeutic area.